Christian Rolfo: Important meeting on Drug Tolerance and Resistance in NSCLC

Christian Rolfo, Associate Director of Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute at Mount Sinai Health System, shared the following post by International Association for the Study of Lung Cancer (IASLC) on X, adding the following:

“Important meeting on Drug Tolerance and Resistance in NSCLC. Please submit your abstract! Great opportunity to discuss on translational research. See you all in Washington DC!”

Quoting International Association for the Study of Lung Cancer (IASLC)’s post:

“Deadline Extended! Submit your abstract to dive deep into the mechanisms, biomarkers & models that drive our understanding/treatment of drug tolerance/resistance in NSCLC. Share your groundbreaking research. Contribute to the future of lung cancer therapy.”

Source: Christian Rolfo/X and IASLC/X